DE60014869D1 - Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln - Google Patents

Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln

Info

Publication number
DE60014869D1
DE60014869D1 DE2000614869 DE60014869T DE60014869D1 DE 60014869 D1 DE60014869 D1 DE 60014869D1 DE 2000614869 DE2000614869 DE 2000614869 DE 60014869 T DE60014869 T DE 60014869T DE 60014869 D1 DE60014869 D1 DE 60014869D1
Authority
DE
Germany
Prior art keywords
glaucomatous
scars
compilation
prophylaxis
drainage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE2000614869
Other languages
English (en)
Other versions
DE60014869T2 (de
Inventor
Johan Stjernschantz
Bahram Resul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synphora AB
Original Assignee
Synphora AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora AB filed Critical Synphora AB
Publication of DE60014869D1 publication Critical patent/DE60014869D1/de
Application granted granted Critical
Publication of DE60014869T2 publication Critical patent/DE60014869T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/908—Mechanical repair performed/surgical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60014869T 1999-02-25 2000-02-23 Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln Expired - Fee Related DE60014869T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9900672A SE9900672D0 (sv) 1999-02-25 1999-02-25 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
SE9900672 1999-02-25
PCT/SE2000/000357 WO2000050040A1 (en) 1999-02-25 2000-02-23 Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula

Publications (2)

Publication Number Publication Date
DE60014869D1 true DE60014869D1 (de) 2004-11-18
DE60014869T2 DE60014869T2 (de) 2006-03-09

Family

ID=20414625

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60014869T Expired - Fee Related DE60014869T2 (de) 1999-02-25 2000-02-23 Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln

Country Status (9)

Country Link
US (1) US6495563B1 (de)
EP (1) EP1161245B1 (de)
JP (1) JP2003521467A (de)
AT (1) ATE279197T1 (de)
AU (1) AU767411B2 (de)
CA (1) CA2363131A1 (de)
DE (1) DE60014869T2 (de)
SE (1) SE9900672D0 (de)
WO (1) WO2000050040A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090162417A1 (en) * 2007-12-21 2009-06-25 Cook Incorporated Drug eluting ocular conformer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981880A (en) 1969-03-14 1976-09-21 The Upjohn Company Racemic prostaglandins of the 2-series and analogs thereof
US3954844A (en) 1975-01-03 1976-05-04 G. D. Searle & Co. (5Z,13E,15S)-15-Hydroxy-11-oxoprosta-5,9.13-trien-1-oic acid and esters
JPS58216155A (ja) 1982-06-10 1983-12-15 Ono Pharmaceut Co Ltd 新規なプロスタグランジンｄ類似化合物
EP0242580B1 (de) * 1986-03-13 1993-04-28 The Trustees Of Columbia University In The City Of New York Verwendung von A-, B- und C-Prostaglandinen und deren Derivaten zur Behandlung von Augen-Hypertension und Glaukom
ATE108330T1 (de) 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
JP2721414B2 (ja) * 1988-09-06 1998-03-04 フアーマシア・アンド・アツプジヨン・アー・ベー 縁内障または眼圧亢進の治療のためのプロスタグランジン誘導体
EP0580268B1 (de) 1988-10-01 1998-01-14 R-Tech Ueno Ltd. Oculare hypotensive Mittel
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
SE9401087D0 (sv) 1994-03-31 1994-03-31 Pharmacia Ab New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
SE9403158D0 (sv) 1994-09-21 1994-09-21 Pharmacia Ab New use of prostaglandins

Also Published As

Publication number Publication date
EP1161245A1 (de) 2001-12-12
US6495563B1 (en) 2002-12-17
EP1161245B1 (de) 2004-10-13
CA2363131A1 (en) 2000-08-31
SE9900672D0 (sv) 1999-02-25
AU767411B2 (en) 2003-11-06
WO2000050040A8 (en) 2003-02-06
AU3340200A (en) 2000-09-14
ATE279197T1 (de) 2004-10-15
WO2000050040A1 (en) 2000-08-31
JP2003521467A (ja) 2003-07-15
DE60014869T2 (de) 2006-03-09

Similar Documents

Publication Publication Date Title
DE60029186D1 (de) Keramischer Schaumkörper
DE60229041D1 (de) Verfahren zur erhöhung der leptinspiegel unter verwendung von nikotinsäureverbindungen
DE60137950D1 (de) Verfahren zur herstellung vitamin-k-abhängiger proteine
ATE345803T1 (de) Neue methoden unter verwendung von cholinesteraseinhibitoren
ATE339185T1 (de) Verfahren zur behandlung von entzündungsbedingten zuständen der augen
ATE304358T1 (de) (s,s)-reboxetin zur behandlung von migränekopfschmerzen
DE60204225D1 (de) Verwendung von biologisch aktivem glas zum schneiden von biologisch aktivem glas
WO2003047513A3 (en) Method for treating ocular hypertension
DE60134581D1 (de) Verfahren zur Herstellung von Siliziumkarbideinkristall
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60139466D1 (de) Behandlung von diabetes
DE50204952D1 (de) Verfahren zur herstellung von rekombinantem trypsin
ATE321850T1 (de) Verfahren zur herstellung von polynucleotivarianten
ATE409693T1 (de) Verfahren zur herstellung von 2-(4- chlorbenzoylamino-3- 2(1h)-chinolinon-4-yl propionsäure
DE60001845D1 (de) Verfahren zur erzeugung und anpassung von kontaktlinsen unter berücksichtigung der materialeigenschaften von linsen
DE60014869D1 (de) Methode und zusammenstellung zur prophylaxe der narbenbildung bei glaukomatösen filtrationsblasen und drainagefisteln
DE60228724D1 (de) Verfahren zur herstellung von beraprost und dessen salzen
BR0314459A (pt) Método para baixar e controlar a pressão intra-ocular e/ou para o tratamento de mamìferos sofrendo a partir de glaucoma e composto
MXPA04006029A (es) Derivados novedosos de benzofuranimidazolina y benzodifuranimidazolina y su uso para el tratamiento de glaucoma.
WO2004054572A3 (en) Novel benzopyran analogs and their use for the treatment of glaucoma
NO20030919D0 (no) Trombomodulinanaloger til anvendelse ved rekonvalesens etter ryggmargsskade
DE60230652D1 (de) Arylsulfanyl und heteroarylsulfanyl-derivate zur behandlung von schmerz
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
WO2003105724A3 (en) NOVEL MAXI K CHANNEL BLOCKERS, METHODS OF USE AND MANUFACTURING METHODS THEREOF
MXPA04001255A (es) Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee